Bacil Pharma Board Approves ₹50 Crore Fundraising via Equity Instruments

Board approved proposal to raise funds up to Rs. 50 crores through permissible modes including rights issue, preferential issue, convertible securities, or warrants, subject to regulatory and shareholder approvals. Specific mode, pricing, and terms to be determined later.